Protective efficacy of Ad26.COV2.S against SARS-CoV-2 B.1.351 in macaques - Yu, Jingyou; Tostanoski, Lisa H.; Mercado, Noe B.; McMahan, Katherine; Liu, Jinyan; Jacob-Dolan, Catherine; Chandrashekar, Abishek; Atyeo, Caroline; Martinez, David R.; Anioke, Tochi; Bondzie, Esther A.; Chang, Aiquan; et al. (Nature (London), 2021)
Keywords: 13/1; 13/31; 631/326/590; 631/326/596/4130; 64; Ad26COVS1; Animals; Antibodies; Antibodies, Neutralizing - immunology; Antibodies, Viral - immunology; Bronchoalveolar Lavage Fluid - virology; Bronchus; CD4 antigen; CD8 antigen; Coronaviruses; COVID-19; COVID-19 - immunology; COVID-19 - pathology; COVID-19 - prevention & control; COVID-19 - virology; COVID-19 vaccines; COVID-19 Vaccines - immunology; Enzymes; Female; Histopathology; Humanities and Social Sciences; Immune response (cell-mediated); Immune response (humoral); Immunity, Cellular; Immunity, Humoral; Immunization; Lavage; Lymphocytes; Lymphocytes T; Macaca mulatta - immunology; Macaca mulatta - virology; Male; multidisciplinary; Neutralizing; Nose - virology; Robustness; SARS-CoV-2 - growth & development; SARS-CoV-2 - immunology; SARS-CoV-2 - pathogenicity; Science; Science (multidisciplinary); Severe acute respiratory syndrome coronavirus 2; Spike protein; T-Lymphocytes - immunology; Vaccines; Viral diseases; Virus Replication; Viruses; United States; South Africa